1. Magnesium isoglycyrrhizinate ameliorates concanavalin A-induced liver injury via the p38 and JNK MAPK pathway
- Author
-
Yudi Gao, Xiangying Zhang, Feng Ren, Xiaohui Zhang, Yu Chen, Yuan Tian, and Zhongping Duan
- Subjects
0301 basic medicine ,Jnk mapk ,Male ,p38 mitogen-activated protein kinases ,Immunology ,Inflammation ,Apoptosis ,Magnesium isoglycyrrhizinate ,Disease ,Pharmacology ,Toxicology ,p38 Mitogen-Activated Protein Kinases ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Concanavalin A ,Immunology and Allergy ,Animals ,Phosphorylation ,Pathological ,Cells, Cultured ,Liver injury ,Mice, Inbred BALB C ,biology ,business.industry ,Macrophages ,JNK Mitogen-Activated Protein Kinases ,General Medicine ,Saponins ,medicine.disease ,Triterpenes ,Disease Models, Animal ,030104 developmental biology ,Liver ,030220 oncology & carcinogenesis ,biology.protein ,Cytokines ,medicine.symptom ,Chemical and Drug Induced Liver Injury ,business ,Signal Transduction - Abstract
Acute liver failure is a serious disease caused by a variety of factors, and immunological injury is an important pathological process. Comprehensive liver treatment efficacy is poor, and the mortality rate is high. Magnesium isoglycyrrhizinate (MgIG) is a new glycyrrhizin drug extracted from the traditional Chinese medicine licorice. The mechanism by which MgIG regulates ConcanavalinA (ConA)-induced immunological liver injury in mice is not completely clear.Immunological liver injury was induced in mice by ConA injection, and the inflammatory macrophages model was induced by lipopolysaccharide (LPS). MgIG was administered 30 min prior to ConA and LPS treatment. The mice in the different groups were sacrificed 12 h after treatment, and macrophages were measured at 30 min, 1 h, and 2 h after induction. Macrophages, liver, and blood samples were then collected for analysis.After drug administration, the MgIG group showed a marked decrease in serum transaminase levels, reduced apoptosis and hepatic inflammatory responses compared to the ConA group. Furthermore, there was a significant reduction in inflammatory cytokine levels in the serum and liver tissue.These findings demonstrated that MgIG protects against ConA-induced immunological liver injury by markedly alleviating liver inflammation, and this provides guidance for the clinical amelioration of liver inflammation induced by immunological factors.
- Published
- 2020